Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
7.83
-0.38 (-4.63%)
At close: Sep 3, 2025, 4:00 PM
7.85
+0.02 (0.26%)
After-hours: Sep 3, 2025, 4:31 PM EDT

Emergent BioSolutions Stock Forecast

Stock Price Forecast

The 3 analysts that cover Emergent BioSolutions stock have a consensus rating of "Strong Buy" and an average price target of $14.33, which forecasts a 83.01% increase in the stock price over the next year. The lowest target is $12 and the highest is $16.

Price Target: $14.33 (+83.01%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$12$14.33$15$16
Change+53.26%+83.01%+91.57%+104.34%

Analyst Ratings

The average analyst rating for Emergent BioSolutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy333333
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong BuyReiterates$15+91.57%Sep 3, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong BuyReiterates$15+91.57%Apr 1, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong BuyReiterates$15+91.57%Mar 21, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong BuyReiterates$15+91.57%Mar 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong BuyReiterates$15+91.57%Jan 21, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
794.97M
from 1.04B
Decreased by -23.82%
Revenue Next Year
947.89M
from 794.97M
Increased by 19.24%
EPS This Year
1.20
from -3.60
EPS Next Year
1.54
from 1.20
Increased by 27.73%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.58B1.77B1.12B1.05B1.04B794.97M947.89M
Revenue Growth
42.61%12.45%-36.99%-6.10%-0.54%-23.82%19.24%
EPS
5.684.06-4.22-14.85-3.601.201.54
EPS Growth
446.15%-28.52%----27.73%
Forward PE
-----6.515.10
No. Analysts
-----42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025202620272029
High830.7M1.3B
Avg795.0M947.9M
Low767.4M668.4M

Revenue Growth

Revenue Growth2025202620272029
High
-20.4%
57.9%
Avg
-23.8%
19.2%
Low
-26.5%
-15.9%

EPS Forecast

EPS20252026
High1.251.60
Avg1.201.54
Low1.171.49

EPS Growth

EPS Growth20252026
High-
32.8%
Avg-
27.7%
Low-
23.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.